<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6031019</article-id>
    <article-id pub-id-type="pmid">29186349</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btx744</article-id>
    <article-id pub-id-type="publisher-id">btx744</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Notes</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Genome Analysis</subject>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>GDSCTools for mining pharmacogenomic interactions in cancer</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Cokelaer</surname>
          <given-names>Thomas</given-names>
        </name>
        <xref ref-type="aff" rid="btx744-aff1">1</xref>
        <xref ref-type="corresp" rid="btx744-cor1"/>
        <!--<email>thomas.cokelaer@pasteur.fr</email>-->
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Chen</surname>
          <given-names>Elisabeth</given-names>
        </name>
        <xref ref-type="aff" rid="btx744-aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Iorio</surname>
          <given-names>Francesco</given-names>
        </name>
        <xref ref-type="aff" rid="btx744-aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Menden</surname>
          <given-names>Michael P</given-names>
        </name>
        <xref ref-type="aff" rid="btx744-aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lightfoot</surname>
          <given-names>Howard</given-names>
        </name>
        <xref ref-type="aff" rid="btx744-aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Saez-Rodriguez</surname>
          <given-names>Julio</given-names>
        </name>
        <xref ref-type="aff" rid="btx744-aff3">3</xref>
        <xref ref-type="aff" rid="btx744-aff5">5</xref>
        <xref ref-type="corresp" rid="btx744-cor1"/>
        <xref ref-type="author-notes" rid="btx744-FM2"/>
        <!--<email>saezrodriguez.rwth-aachen.de</email>-->
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Garnett</surname>
          <given-names>Mathew J</given-names>
        </name>
        <xref ref-type="aff" rid="btx744-aff2">2</xref>
        <xref ref-type="corresp" rid="btx744-cor1"/>
        <xref ref-type="author-notes" rid="btx744-FM2"/>
        <!--<email>mg12@sanger.ac.uk</email>-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Hancock</surname>
          <given-names>John</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <aff id="btx744-aff1"><label>1</label>Institut Pasteur—Bioinformatics and Biostatistics Hub—C3BI, USR IP CNRS, Paris, France</aff>
    <aff id="btx744-aff2"><label>2</label>Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK</aff>
    <aff id="btx744-aff3"><label>3</label>European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Cambridge, UK</aff>
    <aff id="btx744-aff4"><label>4</label>Oncology Innovative Medicines and Early Development, AstraZeneca, Cambridge, UK</aff>
    <aff id="btx744-aff5"><label>5</label>RWTH Aachen University, Joint Research Centre for Computational Biomedicine, Aachen, Germany</aff>
    <author-notes>
      <fn id="btx744-FM2">
        <p>The authors wish it to be known that Julio Saez-Rodriguez and Mathew J. Garnett authors contributed equally.</p>
      </fn>
      <corresp id="btx744-cor1">To whom correspondence should be addressed. Email: <email>thomas.cokelaer@pasteur.fr</email> or <email>saezrodriguez.rwth-aachen.de</email> or <email>mg12@sanger.ac.uk</email></corresp>
    </author-notes>
    <pub-date pub-type="ppub">
      <day>01</day>
      <month>4</month>
      <year>2018</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2017-11-24">
      <day>24</day>
      <month>11</month>
      <year>2017</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>24</day>
      <month>11</month>
      <year>2017</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
    <volume>34</volume>
    <issue>7</issue>
    <fpage>1226</fpage>
    <lpage>1228</lpage>
    <history>
      <date date-type="received">
        <day>28</day>
        <month>7</month>
        <year>2017</year>
      </date>
      <date date-type="rev-recd">
        <day>19</day>
        <month>10</month>
        <year>2017</year>
      </date>
      <date date-type="accepted">
        <day>23</day>
        <month>11</month>
        <year>2017</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author 2017. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license license-type="cc-by-nc" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btx744.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Motivation</title>
        <p>Large pharmacogenomic screenings integrate heterogeneous cancer genomic datasets as well as anti-cancer drug responses on thousand human cancer cell lines. Mining this data to identify new therapies for cancer sub-populations would benefit from common data structures, modular computational biology tools and user-friendly interfaces.</p>
      </sec>
      <sec id="s2">
        <title>Results</title>
        <p>We have developed GDSCTools: a software aimed at the identification of clinically relevant genomic markers of drug response. The Genomics of Drug Sensitivity in Cancer (GDSC) database (<ext-link ext-link-type="uri" xlink:href="http://www.cancerRxgene.org">www.cancerRxgene.org</ext-link>) integrates heterogeneous cancer genomic datasets as well as anti-cancer drug responses on a thousand cancer cell lines. Including statistical tools (analysis of variance) and predictive methods (Elastic Net), as well as common data structures, GDSCTools allows users to reproduce published results from GDSC and to implement new analytical methods. In addition, non-GDSC data resources can also be analysed since drug responses and genomic features can be encoded as CSV files.</p>
      </sec>
      <sec id="s4">
        <title>Supplementary information</title>
        <p><xref ref-type="supplementary-material" rid="sup1">Supplementary data</xref> are available at <italic>Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <counts>
      <page-count count="3"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Cancers occur due to genetic alterations in cells accumulated through the lifespan of an individual. Cancers are genetically heterogeneous and as a consequence patients with similar diagnoses may vary in their response to the same therapy. The path towards precision cancer medicine requires the identification of specific biomarkers, such as genetic alterations, allowing effective patient selection strategies for therapy. Large-scale pharmacological screens such as the Genomics of Drug Sensitivity in Cancer (GDSC) (<xref rid="btx744-B3" ref-type="bibr">Garnett <italic>et al.</italic>, 2012</xref>) and Cancer Cell Line Encyclopaedia projects (<xref rid="btx744-B1" ref-type="bibr">Barretina <italic>et al.</italic>, 2012</xref>) have been used to identify potential new treatments and to explore biomarkers of drug sensitivity in cancer cells. In particular, the GDSC project releases database resources periodically (<ext-link ext-link-type="uri" xlink:href="http://www.cancerRxgene.org">www.cancerRxgene.org</ext-link>) (<xref rid="btx744-B9" ref-type="bibr">Yang <italic>et al.</italic>, 2013</xref>). A recent installment of this resource (version 17) includes cancer-driven alterations identified in 11 289 tumors from 29 tissues across 1001 molecularly annotated human cancer cell lines, and cell line sensitivity data for 265 anti-cancer compounds. A systematic identification of clinically-relevant markers of drug response uncovered numerous alterations that sensitize to anti-cancer drugs (<xref rid="btx744-B4" ref-type="bibr">Iorio <italic>et al.</italic>, 2016</xref>).</p>
    <p>Here, we present GDSCTools, a Python library that allows users to perform pharmacogenomic analyses as those presented in (<xref rid="btx744-B4" ref-type="bibr">Iorio <italic>et al.</italic>, 2016</xref>). Our software complements an existing tool (<xref rid="btx744-B6" ref-type="bibr">Smirnov <italic>et al.</italic>, 2016</xref>) by giving access to the full GDSC dataset and providing a powerful platform for statistical analyses and data mining through visualization tools.</p>
  </sec>
  <sec>
    <title>2 Data formats and data wrangling tools</title>
    <p>The GDSC database provides large-scale genomics and drug sensitivity datasets. The drug sensitivity dataset contains dose-response curves (e.g. cell viability for 5–9 drug concentrations) which can be used to derive drug sensitivity indicators (<xref rid="btx744-B3" ref-type="bibr">Garnett <italic>et al.</italic>, 2012</xref>; <xref rid="btx744-B8" ref-type="bibr">Vis <italic>et al.</italic>, 2016</xref>), such as the half-maximal inhibitory concentration (<inline-formula id="IE1"><mml:math id="IM1"><mml:mrow><mml:msub><mml:mrow><mml:mtext>IC</mml:mtext></mml:mrow><mml:mrow><mml:mn>50</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>) or the area under the curve (AUC) (<xref ref-type="fig" rid="btx744-F1">Fig. 1A</xref>). In GDSCTools, logged <inline-formula id="IE2"><mml:math id="IM2"><mml:mrow><mml:msub><mml:mrow><mml:mtext>IC</mml:mtext></mml:mrow><mml:mrow><mml:mn>50</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula> indicators are encoded as a <italic>N</italic><sub>c</sub> × <italic>N</italic><sub>d</sub> matrix, where <italic>N</italic><sub>c</sub> is the number of cell lines labeled with their COSMIC identifier (<ext-link ext-link-type="uri" xlink:href="http://cancer.sanger.ac.uk/cosmic">http://cancer.sanger.ac.uk/cosmic</ext-link>) and <italic>N</italic><sub>d</sub> is the number of drugs. For a given drug, we denote with <bold>Y</bold><sub>d</sub> the vector of logged <inline-formula id="IE3"><mml:math id="IM3"><mml:mrow><mml:msub><mml:mrow><mml:mtext>IC</mml:mtext></mml:mrow><mml:mrow><mml:mn>50</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>s across the <italic>N</italic><sub>c</sub> cell lines. The genomic feature dataset <inline-formula id="IE4"><mml:math id="IM4"><mml:mi mathvariant="bold">X</mml:mi></mml:math></inline-formula> is also encoded as a <italic>N</italic><sub>c</sub> × <italic>N</italic><sub>f</sub> matrix, where <italic>N</italic><sub>f</sub> is the number of genomic features. In addition to a subset of the data files available in GDSCTools (version 17 only), users can also retrieve additional datasets online (e.g. methylation data, copy number variants, etc.) Database-like queries can be used to extract and use specific features (e.g. only gene amplifications or deletions). These database-like functionalities are part of the <italic>OmniBEM</italic> builder (<xref ref-type="supplementary-material" rid="sup1">Supplementary Material</xref>).
</p>
    <fig id="btx744-F1" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>(<bold>A</bold>) Drug response (cell viability versus drug concentrations) and derived drug response metrics (AUC and <inline-formula id="IE5"><mml:math id="IM5"><mml:mrow><mml:msub><mml:mrow><mml:mtext>IC</mml:mtext></mml:mrow><mml:mrow><mml:mn>50</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>s). (<bold>B</bold>) Distribution of <inline-formula id="IE6"><mml:math id="IM6"><mml:mrow><mml:msub><mml:mrow><mml:mtext>IC</mml:mtext></mml:mrow><mml:mrow><mml:mn>50</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:math></inline-formula>s in response to a given drug across a dichotomy of cell lines induced by the status of a genomic feature. (<bold>C</bold>) <italic>P</italic>-values from an ANOVA analysis versus signed effect sizes (all drug-genomic feature interactions). (<bold>D</bold>) Weight distributions resulting from training a sparse linear regression model of a given drug response using all the genomic features</p>
      </caption>
      <graphic xlink:href="btx744f1"/>
    </fig>
  </sec>
  <sec>
    <title>3 Data analysis tools</title>
    <p>Using GDSCTools, genomic features can be investigated as possible predictors of differential drug sensitivity across screened cell lines. The statistical interaction <bold>Y</bold><sub>d</sub> ∼ <italic>X</italic> between drug response and genomic features can be tested within a sample population of cell lines from the same cancer type with a <italic>t</italic>-test. However, to account for possible confounding factors (including the tissue of origin, when performing pan-cancer analyses) a more versatile analysis of variance (ANOVA) is implemented. In this model, the variability observed in <bold>Y</bold><sub>d</sub> is first explained using the tissue covariate, subsequently using additional factors (e.g. microsatellite instability denoted by MSI), and finally by each of the genomic features in <italic>X</italic> (one model per feature). This can be mathematically expressed as <italic>Y</italic><sub>d</sub> ∼ <italic>C</italic>(tissue) + <italic>C</italic>(MSI) + … + feature, where the <inline-formula id="IE7"><mml:math id="IM7"><mml:mrow><mml:mi>C</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></inline-formula> operator indicates a categorical variable. An ANOVA test is performed for each combination of drug and genomic feature (<xref ref-type="fig" rid="btx744-F1">Fig. 1B</xref>). Outcomes of this large number of tests (<italic>N</italic><sub>d</sub> × <italic>N</italic><sub>f</sub>) are corrected for multiple hypothesis testing using Bonferroni or Benjamini-Hochberg corrections. To account for <italic>P</italic>-value inflations due to differences in sample sizes, the effect sizes of the tested statistical interactions (computed with the Cohen and Glass models) are also included (<xref ref-type="fig" rid="btx744-F1">Fig. 1C</xref>).</p>
    <p>Unlike the ANOVA analysis that is performed on a one drug/one feature basis, linear regression models assume that drug response can be expressed as a linear combination of the status of a set of genomic features. GDSCTools includes three linear regression methods: (i) Ridge, based on an L2 penalty term, which limits the size of the coefficient vector; (ii) Lasso, based on an L1 penalty term, which imposes sparsity among the coefficients (i.e. makes the fitted model more interpretable) and (iii) Elastic Net, a compromise between Ridge and Lasso techniques with a mix penalty between L1 and L2 norms (see <xref ref-type="supplementary-material" rid="sup1">Supplementary Material</xref> for details). These three methods require the optimization of an α parameter (importance of L1 and L2 penalties) and a ρ parameter (mix ratio between L1 and L2 penalties; ElasticNet case only). This is performed via a cross validation to avoid over-fitting. The best model is determined using as objective function the Pearson correlation between predicted and actual drug responses on the training set. The final regressor weights are outputted as shown in <xref ref-type="fig" rid="btx744-F1">Figure 1D</xref>. Significance of the final selected models is computed against.</p>
  </sec>
  <sec>
    <title>4 Implementation and future directions</title>
    <p>GDSCTools is available on <ext-link ext-link-type="uri" xlink:href="http://github.com/CancerRxGene/gdsctools">http://github.com/CancerRxGene/gdsctools</ext-link>. It is fully documented on <ext-link ext-link-type="uri" xlink:href="http://gdsctools.readthedocs.io">http://gdsctools.readthedocs.io</ext-link>. Pre-compiled versions of the library are available on <ext-link ext-link-type="uri" xlink:href="https://bioconda.github.io/">https://bioconda.github.io/</ext-link>. GDSCTools can be used via standalone applications to analyse a user defined set of drugs (and genomic features) and assemble the results in an HTML report. We also provide solutions based on the Snakemake framework (<xref rid="btx744-B5" ref-type="bibr">Köster and Rahmann, 2012</xref>) to parallelize the analysis on distributed cluster farm architectures such as LSF or SLURM (<xref ref-type="supplementary-material" rid="sup1">Supplementary Material</xref>). Besides analysis of pharmacogenomic datasets, GDSCTools can provide the framework for discovering new biomarkers through integration/mining of novel and heterogeneous datasets, including pharmacological, RNA interference or increasingly available genetic screens (e.g. CRISPR), alternative drug response metrics (e.g. AUC) or implementing new analytical tools. The augmentation of genomic features with information obtained from online web services (<xref rid="btx744-B2" ref-type="bibr">Cokelaer <italic>et al.</italic>, 2013</xref>) like pathway enrichment [e.g. via OmniPath (<xref rid="btx744-B7" ref-type="bibr">Turei <italic>et al.</italic>, 2016</xref>)] will further extend functionality and usefulness of GDSCTools.</p>
    <p><italic>Conflict of Interest</italic>: none declared.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sup1">
      <label>Supplementary Data</label>
      <media xlink:href="btx744_suppdata.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ref-list>
    <title>References</title>
    <ref id="btx744-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barretina</surname><given-names>J.</given-names></name></person-group><etal>et al</etal> (<year>2012</year>) 
<article-title>The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity</article-title>. <source>Nature</source>, <volume>492</volume>, <fpage>290.</fpage></mixed-citation>
    </ref>
    <ref id="btx744-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cokelaer</surname><given-names>T.</given-names></name></person-group><etal>et al</etal> (<year>2013</year>) 
<article-title>BioServices: a common Python package to access biological Web Services programmatically</article-title>. <source>Bioinformatics</source>, <volume>29</volume>, <fpage>3241</fpage>–<lpage>3242</lpage>.<pub-id pub-id-type="pmid">24064416</pub-id></mixed-citation>
    </ref>
    <ref id="btx744-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garnett</surname><given-names>M.J.</given-names></name></person-group><etal>et al</etal> (<year>2012</year>) 
<article-title>Systematic identification of genomic markers of drug sensitivity in cancer cells</article-title>. <source>Nature</source>, <volume>483</volume>, <fpage>570</fpage>–<lpage>575</lpage>.<pub-id pub-id-type="pmid">22460902</pub-id></mixed-citation>
    </ref>
    <ref id="btx744-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iorio</surname><given-names>F.</given-names></name></person-group><etal>et al</etal> (<year>2016</year>) 
<article-title>A landscape of pharmacogenomic interactions in cancer</article-title>. <source>Cell</source>, <volume>166</volume>, <fpage>740</fpage>–<lpage>754</lpage>.<pub-id pub-id-type="pmid">27397505</pub-id></mixed-citation>
    </ref>
    <ref id="btx744-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Köster</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Rahmann</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>) 
<article-title>Snakemake–a scalable bioinformatics workflow engine</article-title>. <source>Bioinformatics</source>, <volume>28</volume>, <fpage>2520</fpage>–<lpage>2522</lpage>.<pub-id pub-id-type="pmid">22908215</pub-id></mixed-citation>
    </ref>
    <ref id="btx744-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smirnov</surname><given-names>P.</given-names></name></person-group><etal>et al</etal> (<year>2016</year>) 
<article-title>PharmacoGx: an R package for analysis of large pharmacogenomic datasets</article-title>. <source>Bioinformatics</source>, <volume>32</volume>, <fpage>1244</fpage>–<lpage>1246</lpage>.<pub-id pub-id-type="pmid">26656004</pub-id></mixed-citation>
    </ref>
    <ref id="btx744-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Turei</surname><given-names>D.</given-names></name></person-group><etal>et al</etal> (<year>2016</year>) 
<article-title>OmniPath: guidelines and gateway for literature-curated signaling pathway resources</article-title>. <source>Nat. Methods</source>, <volume>13</volume>, <fpage>966</fpage>–<lpage>967</lpage>.<pub-id pub-id-type="pmid">27898060</pub-id></mixed-citation>
    </ref>
    <ref id="btx744-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vis</surname><given-names>D.J.</given-names></name></person-group><etal>et al</etal> (<year>2016</year>) 
<article-title>Multilevel models improve precision and speed of IC50 estimates</article-title>. <source>Pharmacogenomics</source>, <volume>17</volume>, <fpage>691</fpage>–<lpage>700</lpage>.<pub-id pub-id-type="pmid">27180993</pub-id></mixed-citation>
    </ref>
    <ref id="btx744-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>W.</given-names></name></person-group><etal>et al</etal> (<year>2013</year>) 
<article-title>Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells</article-title>. <source>Nucleic Acids Res</source>., <volume>41</volume>, <fpage>D955</fpage>–<lpage>D961</lpage>.<pub-id pub-id-type="pmid">23180760</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
